News

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.

Bootstrap Bio...

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so...

Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my...

"Donald Trump Signs The Pledge" by Michael Vadon 
is licensed under CC BY-SA 2.0.

This is...

By Cormac Sheridan, Nature | 07.15.2021

A recent study has identified another potential hazard for developers of genome editing therapies based on CRISPR–Cas9. The double-strand DNA...

sickle cells
By Ted W. Love, STAT | 07.15.2021

Covid-19 laid bare the long-standing vulnerability of minority and low-income communities in U.S. society and its health system even as...

a lab mouse sitting in a gloved hand
By Megan Molteni, STAT | 07.15.2021

The tiny clump of mouse cells didn’t look like an ovary. For one thing, it was much smaller, microscopic. And...

Peter Mills
By Peter Mills, Nuffield Council on Bioethics | 07.14.2021

In 2019, the World Health Organization convened an Expert Advisory Committee on Developing Global Standards for Governance and Oversight of...

disabled sign
By s.e. smith, The Nation | 07.14.2021

Imagining better worlds can help us improve our own, but literary and cinematic utopias often exclude those who don’t fit...

Cleveland Clinic Miller Family Pavilion
By Pam Belluck, New York Times | 07.14.2021

The Cleveland Clinic Miller Family Pavilion
HealthMonitor, CC BY-SA 4.0,
via Wikimedia Commons

In a striking reflection of concern...

Biogen logo
By Jonathan Saltzman, Boston Globe | 07.13.2021

At least half-a-dozen private health insurers in some of the nation’s largest states are balking at covering Biogen’s controversial drug...

Hastings Center logo
By Carl Elliott, Hastings Center Report | 07.13.2021

Abstract

Activism is rare among clinical ethicists because the position of ethics consultant is constructed in a way that makes...